×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
北京航空航天大学 [16]
化学研究所 [15]
中国医学科学院 北京... [8]
复旦大学上海医学院 [7]
兰州大学 [6]
武汉大学 [4]
更多...
内容类型
期刊论文 [72]
会议论文 [12]
发表日期
2022 [2]
2020 [2]
2019 [9]
2018 [14]
2017 [15]
2016 [21]
更多...
学科主题
Chemistry [1]
Electricit... [1]
Materials ... [1]
informatio... [1]
mathematic... [1]
mathematic... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共84条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
期刊论文
LIVER CANCER, 2022, 卷号: 11
作者:
Sun, Yongkun
;
Zhang, Wen
;
Bi, Xinyu
;
Yang, Zhengqiang
;
Tang, Yu
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/12/23
Chinese interdisciplinary experts
Hepatocellular carcinoma
Molecular targeted therapy
Consensus
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:
Zhou, Qing
;
Chen, Ming
;
Jiang, Ou
;
Pan, Yi
;
Hu, Desheng
收藏
  |  
浏览/下载:104/0
  |  
提交时间:2022/03/21
Tracing interaction between hydrocarbon and groundwater systems with isotope signatures preserved in the Anyue gas field, central Sichuan Basin, China
期刊论文
GEOCHIMICA ET COSMOCHIMICA ACTA, 2020, 卷号: 274, 页码: 261-285
作者:
Li, Yan
;
Qin, Shengfei
;
Wang, Yunpeng
;
Holland, Greg
;
Zhou, Zheng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/04/27
Tracing interaction between hydrocarbon and groundwater systems with isotope signatures preserved in the Anyue gas field, central Sichuan Basin, China
期刊论文
GEOCHIMICA ET COSMOCHIMICA ACTA, 2020, 卷号: 274, 页码: 261-285
作者:
Li, Yan
;
Qin, Shengfei
;
Wang, Yunpeng
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2021/11/10
SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1
期刊论文
NUCLEIC ACIDS RESEARCH, 2019, 卷号: 47, 期号: 17, 页码: 9053-9068
作者:
Zhang, Huifang
;
Gao, Qinqin
;
Tan, Shuo
;
You, Jia
;
Lyu, Cong
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2020/09/10
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:112/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 卷号: 145, 期号: 3
作者:
Xu, Jianmin
;
Fan, Jia
;
Qin, Xinyu
;
Cai, Jianqiang
;
Gu, Jin
收藏
  |  
浏览/下载:87/0
  |  
提交时间:2019/12/05
Colorectal neoplasms
Liver metastases
Diagnosis
Comprehensive treatment
Guideline
Porous metal-organic framework Carrier for incorporation of volatile antimicrobial essential oil
期刊论文
Food Control, 2019, 卷号: Vol.98, 页码: 174-178
作者:
Yunpeng Wu
;
Yaguang Luo
;
Bin Zhou
;
Lei Mei
;
Qin Wang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/13
Metal-organic
framework
Thymol
Antimicrobial
property
Thermomechanical response of copper films irradiated by femtosecond-pulsed lasers with dynamic optical properties
期刊论文
APPLIED OPTICS, 2019, 卷号: 58, 期号: 4, 页码: 871-878
作者:
Ren, Yunpeng[1]
;
Qin, Kai[2]
;
Chen, Yan[3]
;
Lin, Qing[4]
;
Xu, Dongyang[5]
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/24
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2020/01/03
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
©版权所有 ©2017 CSpace - Powered by
CSpace